SCHEMBL13493674

SCHEMBL13493674

CCc1cc2cc(-c3c(Cl)nc(NC(C)C)nc3N[C@@H]3C[C@H](CO)[C@@H](C)C3)oc2cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13493691 0.88 CCNT1 (0.30) —
SCHEMBL12058119 0.87 IRAK4 (0.35) —
SCHEMBL12057682 0.86 PTGES (0.31) —
SCHEMBL13493670 0.86 EHMT2 (0.31) —
SCHEMBL12037915 0.86 IRAK4 (0.38) —
SCHEMBL12058369 0.86 — —
SCHEMBL12058368 0.82 ESR1 (0.31) —
SCHEMBL12057912 0.79 — —
SCHEMBL12058381 0.78 ESR1 (0.31) —
SCHEMBL12057832 0.78 ESR1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010022121-A1 SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS SCHERING CORPORATION (US) 2010-02-25 — — WO disclosed
Send feedback